Logo

Getting Personal: Mar 22, 2007

Mar 23, 2007

Omics! Omics! blogger Keith Robison posts at length on the story -- published in a December issue of Blood -- of Millennium Pharmaceuticals' quest to find a personalized treatment for multiple myeloma. For the first time in clinical trials, they used a genomics technique called RNA profiling to introduce a personalized medicine component to their trials. Effectively, finding and utilizing personalized information is a long way off, Robison believes.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.